Related references
Note: Only part of the references are listed.A Review of Research Progress in Multidrug-Resistance Mechanisms in Gastric Cancer
Tuo Ruan et al.
ONCOTARGETS AND THERAPY (2020)
Characterization of Tailoring Steps of Nargenicin A1 Biosynthesis Reveals a Novel Analogue with Anticancer Activities
Dipesh Dhakal et al.
ACS CHEMICAL BIOLOGY (2020)
Recent Developments of Systemic Chemotherapy for Gastric Cancer
Hiroyuki Arai et al.
CANCERS (2020)
Novel Nargenicin A1 Analog Inhibits Angiogenesis by Downregulating the Endothelial VEGF/VEGFR2 Signaling and Tumoral HIF-1α/VEGF Pathway
Jang Mi Han et al.
BIOMEDICINES (2020)
Recent advances in gastric cancer early diagnosis
Laura Necula et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Repressing CD147 is a novel therapeutic strategy for malignant melanoma
Xing Hu et al.
ONCOTARGET (2017)
Gastric adenocarcinoma
Jaffer A. Ajani et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Recent strategies for treating stage IV gastric cancer: roles of palliative gastrectomy, chemotherapy, and radiotherapy
Journal of Gastrointestinal and Liver Diseases (2016)
Elucidation of DnaE as the Antibacterial Target of the Natural Product, Nargenicin
Ronald E. Painter et al.
CHEMISTRY & BIOLOGY (2015)
Cyclophilin A Enhances Cell Proliferation and Xenografted Tumor Growth of Early Gastric Cancer
Wenhua Feng et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Global burden of gastric cancer attributable to Helicobacter pylori
Martyn Plummer et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Parisa Karimi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
CD147 Expression in Human Gastric Cancer Is Associated with Tumor Recurrence and Prognosis
Dake Chu et al.
PLOS ONE (2014)
Cyclophilin A: a key player for human disease
P. Nigro et al.
CELL DEATH & DISEASE (2013)
Basigin: a multifunctional membrane protein with an emerging role in infections by malaria parasites
Takashi Muramatsu
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
GSTM1 null allele is a risk factor for gastric cancer development in Asians
Li-Xin Qiu et al.
CYTOKINE (2011)
Glutathione S-transferase M1 Gene Polymorphism and Gastric Cancer Risk: An Updated Analysis
Bo Chen et al.
ARCHIVES OF MEDICAL RESEARCH (2010)
Role of Cyclophilin A during Oncogenesis
Jinhwa Lee
ARCHIVES OF PHARMACAL RESEARCH (2010)
Heat Shock Protein 60 Regulation of the Mitochondrial Permeability Transition Pore in Tumor Cells
Jagadish C. Ghosh et al.
CANCER RESEARCH (2010)
Activation of CD147 with Cyclophilin A Induces the Expression of IFITM1 through ERK and PI3K in THP-1 Cells
Ju-Young Kim et al.
MEDIATORS OF INFLAMMATION (2010)
Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer
Jiamao Zheng et al.
CANCER RESEARCH (2008)
Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal
Huirong Yang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis
H-C Zheng et al.
BRITISH JOURNAL OF CANCER (2006)
Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147
M Li et al.
CANCER (2006)
Regulation of CD147 cell surface expression - Involvement of the proline residue in the CD147 transmembrane domain
V Yurchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
Active site residues of cyclophilin A are crucial for its signaling activity via CD147
V Yurchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Cell-surface trafficking and release of flt3 ligand from T lymphocytes is induced by common cytokine receptor γ-chain signaling and inhibited by cyclosporin A
E Chklovskaia et al.
BLOOD (2001)
Post-translational reduction of cell surface expression of insulin receptors by cyclosporin A, FK506 and rapamycin in bovine adrenal chromaffin cells
S Shiraishi et al.
NEUROSCIENCE LETTERS (2000)
Share Paper
